熱門資訊> 正文
LIPR、ELDN和IVP均为上市前输家
2024-05-13 20:19
- AEye Inc Ordinary Shares - Class A(LIDR) 0
- Eledon Pharmaceuticals Inc Ordinary Shares(ELDN) 0
- Seritage Growth Properties(SRG) 0
- Losers: Seritage Growth Properties (SRG) -28% after Q1 earnings release.
- Antelope Enterprise Holdings Ltd (AEHL) -18%.
- Eastside Distilling (EAST) -17%.
- Applied Dna Sciences (APDN) -15% after Q2 earnings release.
- AEye (LIDR) -14%.
- Treasure Global (TGL) -11% announces 2024 annual general meeting of shareholders.
- TransCode Therapeutics (RNAZ) -13%.
- Inspire Veterinary Partners (IVP) -10%.
- Fortrea Holdings (FTRE) -9% after Q1 earnings release.
- Eledon Pharmaceuticals (ELDN) -7%.
- Pop Culture Group Co Ltd (CPOP) -6%.
- Dingdong Ltd (DDL) -5%.
More on pre-market losers & stocks.
- AEye, Inc. (LIDR) Q4 2023 Earnings Call Transcript
- World’s first pig-to-human kidney transplant performed in U.S
- Seeking Alpha’s Quant Rating on Eledon Pharmaceuticals
- Historical earnings data for Eledon Pharmaceuticals
- Financial information for Eledon Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
